Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 282

The DOI matches its Crossref record; 54 of the 54 references it cites were found in a registry or an index.

Amyloid β Peptide of Alzheimer’s Disease Downregulates Bcl-2 and Upregulates Bax Expression in Human Neurons

Open access
Paradis, Eric, Douillard, Hélène, Koutroumanis, Maria, Goodyer, Cynthia, LeBlanc, Andréa·1996·The Journal of Neuroscience

Abstract

Neuronal apoptosis is a suspected cause of neurodegeneration in Alzheimer’s disease (AD). Increased levels of amyloid β peptide (Aβ) induce neuronal apoptosis in vitro and in vivo. The underlying molecular mechanism of Aβ neurotoxicity is not clear. The normal concentration of Aβ in cerebrospinal fluid is 4 n m. We treated human neuron primary cultures with 100 n m amyloid β peptides Aβ 1–40 and Aβ 1–42 and the control reverse peptide Aβ 40–1. We find that although little neuronal apoptosis is induced by either peptide after 3 d of treatment, Aβ 1–42 provokes a rapid and sustained downregulation of a key anti-apoptotic protein, bcl-2, whereas it increases levels of bax, a protein known to promote cell death. In contrast, the Aβ 1–40 downregulation of bcl-2 is gradual, although the levels are equivalent to those of Aβ 1–42-treated neurons by 72 hr of treatment. Aβ 1–40 does not upregulate bax levels. The control, reverse peptide Aβ 40–1, does not affect either bcl-2 or bax protein levels. In addition, we found that the Aβ 1–40- and Aβ 1–42- but not Aβ 40–1-treated neurons had increased vulnerability to low levels of oxidative stress. Therefore, we propose that although high physiological amounts of Aβ are not sufficient to induce apoptosis, Aβ depletes the neurons of one of its anti-apoptotic mechanisms. We hypothesize that increased Aβ in individuals renders the neurons vulnerable to age-dependent stress and neurodegeneration.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1523/jneurosci.16-23-07533.1996

Cites

54 of 54 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 54 references

Cited by

See all 282

Metadata

Authors
Paradis, E., Douillard, H., Koutroumanis, M., Goodyer, C., & LeBlanc, A.
Venue
The Journal of Neuroscience
Published
1996-12-01
Volume
16
Issue
23
Pages
7533-7539
ISSN
  • 0270-6474 (ISSN-L)
  • 1529-2401
OpenAlex
W4293021036
Cited by
282
References
54
FWCI
8.25
Type
journal article
Language
en
Open access
hybrid

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Amyloid β Peptide of Alzheimer’s Disease Downregulates Bcl-2 and Upregulates Bax Expression in Human Neurons. https://app.cochat.ai/papers/10.1523/jneurosci.16-23-07533.1996
The paper
Paradis, E., Douillard, H., Koutroumanis, M., Goodyer, C., & LeBlanc, A. (1996). Amyloid β Peptide of Alzheimer’s Disease Downregulates Bcl-2 and Upregulates Bax Expression in Human Neurons. The Journal of Neuroscience. https://doi.org/10.1523/jneurosci.16-23-07533.1996

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.